Edwards Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Edwards Lifesciences Corp
EW Stock  USD 70.34  0.29  0.41%   
Edwards Lifesciences financial statements provide useful quarterly and yearly information to potential Edwards Lifesciences Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Edwards Lifesciences financial statements helps investors assess Edwards Lifesciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Edwards Lifesciences' valuation are summarized below:
Gross Profit
4.3 B
Profit Margin
0.7675
Market Capitalization
41.5 B
Enterprise Value Revenue
6.8866
Revenue
5.4 B
There are over one hundred nineteen available fundamental signals for Edwards Lifesciences Corp, which can be analyzed over time and compared to other ratios. All traders should should verify Edwards Lifesciences' prevailing fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to climb to about 45.9 B in 2025. Enterprise Value is likely to climb to about 45.4 B in 2025

Edwards Lifesciences Total Revenue

5.71 Billion

Check Edwards Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Edwards Lifesciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 92.8 M, Interest Expense of 11 M or Selling General Administrative of 1.9 B, as well as many indicators such as Price To Sales Ratio of 4.44, Dividend Yield of 0.0 or PTB Ratio of 4.78. Edwards financial statements analysis is a perfect complement when working with Edwards Lifesciences Valuation or Volatility modules.
  
Check out the analysis of Edwards Lifesciences Correlation against competitors.

Edwards Lifesciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets13.7 B13.1 B6.1 B
Slightly volatile
Other Current Liabilities1.3 B1.2 B515.3 M
Slightly volatile
Total Current Liabilities1.6 B1.5 B814.7 M
Slightly volatile
Total Stockholder Equity10.5 B10 B4.2 B
Slightly volatile
Property Plant And Equipment Net1.9 B1.8 B992 M
Slightly volatile
Retained Earnings13.8 B13.2 B4.9 B
Slightly volatile
Non Current Assets Total7.1 B6.8 B3.3 B
Slightly volatile
Non Currrent Assets Other769 M732.4 M199.7 M
Slightly volatile
Cash And Short Term Investments4.2 B4 B1.5 B
Slightly volatile
Net Receivables385.1 M727.4 M483.8 M
Slightly volatile
Good Will1.9 B1.8 B962.3 M
Slightly volatile
Common Stock Shares Outstanding548 M599.3 M646.3 M
Slightly volatile
Liabilities And Stockholders Equity13.7 B13.1 B6.1 B
Slightly volatile
Non Current Liabilities Total832.8 M1.5 B1.1 B
Slightly volatile
Inventory1.1 B1.1 B603.5 M
Slightly volatile
Other Current Assets520.2 M495.4 M203.9 M
Slightly volatile
Total Liabilities3.1 B3 B2 B
Slightly volatile
Property Plant And Equipment Gross2.7 B2.6 B1.1 B
Slightly volatile
Total Current Assets6.6 B6.3 B2.8 B
Slightly volatile
Short and Long Term Debt Total497.7 M700 M603.7 M
Slightly volatile
Other Liabilities963.1 M917.2 M615.9 M
Slightly volatile
Accounts Payable142.6 M197.4 M135 M
Slightly volatile
Cash3.2 B3 B1 B
Slightly volatile
Other Assets945.6 M900.6 M424.5 M
Slightly volatile
Long Term Debt434.9 M597.7 M522.5 M
Slightly volatile
Common Stock Total Equity780.4 M743.2 M361.2 M
Slightly volatile
Intangible Assets1.2 B1.2 B379 M
Slightly volatile
Common Stock687.5 M654.8 M350.2 M
Slightly volatile
Property Plant Equipment2.1 B2 B996.6 M
Slightly volatile
Short Term Investments977.2 M930.7 M466.6 M
Slightly volatile
Net Tangible Assets5.3 B5 B2.7 B
Slightly volatile
Capital Surpluse1.2 B2.3 B1.2 B
Slightly volatile
Long Term Investments565.9 M307.9 M517.7 M
Slightly volatile
Non Current Liabilities Other479.5 M756.6 M438.6 M
Slightly volatile
Deferred Long Term Asset Charges246.1 M234.4 M160.3 M
Slightly volatile
Long Term Debt Total583.3 M685.7 M523.7 M
Slightly volatile
Short and Long Term Debt719.2 M687.7 M625.2 M
Pretty Stable
Cash And Equivalents1 B884.4 M919.1 M
Very volatile
Net Invested Capital6.6 B10.6 B5.2 B
Slightly volatile
Net Working Capital2.6 B4.8 B1.8 B
Slightly volatile
Capital Stock575.7 M654.8 M372.5 M
Slightly volatile
Capital Lease Obligations105.3 M102.3 M89.9 M
Slightly volatile

Edwards Lifesciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization92.8 M155.2 M104.7 M
Slightly volatile
Selling General Administrative1.9 B1.8 B1.1 B
Slightly volatile
Total Revenue5.7 B5.4 B3.6 B
Slightly volatile
Gross Profit4.5 B4.3 B2.7 B
Slightly volatile
Other Operating Expenses4.3 B4.1 B2.6 B
Slightly volatile
Operating Income1.4 B1.4 B949.5 M
Slightly volatile
Research Development1.1 B1.1 B616 M
Slightly volatile
Cost Of Revenue718.3 M1.1 B848 M
Slightly volatile
Total Operating Expenses3.1 B2.9 B1.8 B
Slightly volatile
Income Before Tax1.6 B1.5 B995.5 M
Slightly volatile
Net Income4.4 B4.2 B1.2 B
Slightly volatile
Income Tax Expense115.2 M152.1 M156.5 M
Pretty Stable
Net Income Applicable To Common Shares1.8 B1.8 B885.2 M
Slightly volatile
Net Income From Continuing Ops883 M1.4 B807.7 M
Slightly volatile
Tax Provision144.3 M152.1 M161.6 M
Pretty Stable
Interest Income126.3 M120.3 M31.2 M
Slightly volatile
Reconciled Depreciation127.7 M155.2 M101.9 M
Slightly volatile
Selling And Marketing Expenses953.3 K1.4 M514.6 K
Slightly volatile

Edwards Lifesciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow439.5 M289.9 M599.9 M
Slightly volatile
Depreciation85.3 M155.2 M93.1 M
Slightly volatile
Capital Expenditures151.7 M252.4 M197.2 M
Slightly volatile
Total Cash From Operating Activities591.1 M542.3 M797.1 M
Slightly volatile
Net Income4.4 B4.2 B1.2 B
Slightly volatile
End Period Cash Flow3.2 B3.1 B1 B
Slightly volatile
Stock Based Compensation170.4 M162.3 M86 M
Slightly volatile
Begin Period Cash Flow1.2 B1.1 B721.2 M
Slightly volatile
Cash Flows Other Operating1.8 B1.7 B896.5 M
Slightly volatile
Issuance Of Capital Stock169.1 M184.6 M154.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.448.13457.3921
Slightly volatile
PTB Ratio4.784.42557.4618
Slightly volatile
Days Sales Outstanding60.2748.809854.4599
Slightly volatile
Book Value Per Share17.6816.8366.727
Slightly volatile
Free Cash Flow Yield0.00620.00660.0319
Slightly volatile
Operating Cash Flow Per Share0.670.90731.2469
Slightly volatile
Stock Based Compensation To Revenue0.02410.02980.0219
Pretty Stable
Capex To Depreciation1.31.62632.0763
Pretty Stable
PB Ratio4.784.42557.4618
Slightly volatile
EV To Sales4.467.70347.3404
Slightly volatile
Free Cash Flow Per Share0.50.4850.9379
Slightly volatile
ROIC0.10.10720.1478
Pretty Stable
Inventory Turnover0.981.02831.6481
Slightly volatile
Net Income Per Share7.336.98441.9391
Slightly volatile
Days Of Inventory On Hand373355237
Slightly volatile
Payables Turnover4.775.66116.8201
Pretty Stable
Sales General And Administrative To Revenue0.360.350.3208
Pretty Stable
Research And Ddevelopement To Revenue0.10.19360.1541
Slightly volatile
Capex To Revenue0.04410.04640.0561
Very volatile
Cash Per Share6.986.6522.3726
Slightly volatile
POCF Ratio85.6781.592737.7419
Slightly volatile
Interest Coverage63.5969.631387.8787
Very volatile
Capex To Operating Cash Flow0.320.46540.2653
Slightly volatile
PFCF Ratio16015356.8371
Slightly volatile
Days Payables Outstanding93.864.475261.6801
Very volatile
Income Quality0.120.13011.1132
Slightly volatile
ROE0.440.41750.246
Slightly volatile
EV To Operating Cash Flow81.1377.268237.0683
Slightly volatile
PE Ratio10.0710.599332.6169
Very volatile
Return On Tangible Assets0.430.41320.2093
Slightly volatile
EV To Free Cash Flow15214555.626
Slightly volatile
Earnings Yield0.09910.09430.0421
Pretty Stable
Intangibles To Total Assets0.310.22620.2326
Pretty Stable
Current Ratio2.374.17583.4677
Pretty Stable
Tangible Book Value Per Share12.4911.89494.6244
Slightly volatile
Receivables Turnover5.457.4786.7598
Slightly volatile
Graham Number53.8451.272116.8598
Slightly volatile
Shareholders Equity Per Share17.5616.72816.7056
Slightly volatile
Debt To Equity0.06650.070.2343
Slightly volatile
Capex Per Share0.440.42230.3258
Slightly volatile
Revenue Per Share9.569.10075.7931
Slightly volatile
Interest Debt Per Share1.261.20431.0017
Slightly volatile
Debt To Assets0.05090.05360.1318
Slightly volatile
Enterprise Value Over EBITDA16.924.318125.2515
Slightly volatile
Short Term Coverage Ratios20.9120.8620.3666
Slightly volatile
Price Earnings Ratio10.0710.599332.6169
Very volatile
Operating Cycle424404291
Slightly volatile
Price Book Value Ratio4.784.42557.4618
Slightly volatile
Days Of Payables Outstanding93.864.475261.6801
Very volatile
Price To Operating Cash Flows Ratio85.6781.592737.7419
Slightly volatile
Price To Free Cash Flows Ratio16015356.8371
Slightly volatile
Pretax Profit Margin0.140.28460.2544
Pretty Stable
Ebt Per Ebit0.641.12291.0606
Pretty Stable
Operating Profit Margin0.160.25350.2413
Slightly volatile
Effective Tax Rate0.09330.09820.18
Slightly volatile
Company Equity Multiplier1.81.30571.5624
Very volatile
Long Term Debt To Capitalization0.05360.05640.156
Slightly volatile
Total Debt To Capitalization0.06220.06540.1721
Slightly volatile
Return On Capital Employed0.140.11940.1845
Very volatile
Debt Equity Ratio0.06650.070.2343
Slightly volatile
Ebit Per Revenue0.160.25350.2413
Slightly volatile
Quick Ratio1.823.45382.7044
Pretty Stable
Dividend Paid And Capex Coverage Ratio3.12.14864.3138
Pretty Stable
Net Income Per E B T2.832.69661.0525
Slightly volatile
Cash Ratio2.122.02311.1393
Slightly volatile
Cash Conversion Cycle356339241
Slightly volatile
Operating Cash Flow Sales Ratio0.170.09970.2335
Pretty Stable
Days Of Inventory Outstanding373355237
Slightly volatile
Days Of Sales Outstanding60.2748.809854.4599
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.570.53460.7279
Slightly volatile
Cash Flow Coverage Ratios1.080.77471.3663
Very volatile
Price To Book Ratio4.784.42557.4618
Slightly volatile
Fixed Asset Turnover4.853.04874.2848
Slightly volatile
Capital Expenditure Coverage Ratio3.12.14864.3138
Pretty Stable
Price Cash Flow Ratio85.6781.592737.7419
Slightly volatile
Enterprise Value Multiple16.924.318125.2515
Slightly volatile
Debt Ratio0.05090.05360.1318
Slightly volatile
Cash Flow To Debt Ratio1.080.77471.3663
Very volatile
Price Sales Ratio4.448.13457.3921
Slightly volatile
Return On Assets0.340.31980.1638
Slightly volatile
Asset Turnover0.790.41670.669
Slightly volatile
Net Profit Margin0.810.76750.2814
Slightly volatile
Gross Profit Margin0.540.79460.7217
Pretty Stable
Price Fair Value4.784.42557.4618
Slightly volatile
Return On Equity0.440.41750.246
Slightly volatile

Edwards Lifesciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap45.9 B43.7 B37.4 B
Slightly volatile
Enterprise Value45.4 B43.3 B37.1 B
Slightly volatile

Edwards Fundamental Market Drivers

Forward Price Earnings28.4091
Cash And Short Term Investments4 B

Edwards Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Edwards Lifesciences Financial Statements

Edwards Lifesciences investors use historical fundamental indicators, such as Edwards Lifesciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Edwards Lifesciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue53.7 M51 M
Total Revenue5.4 B5.7 B
Cost Of Revenue1.1 B718.3 M
Stock Based Compensation To Revenue 0.03  0.02 
Sales General And Administrative To Revenue 0.35  0.36 
Research And Ddevelopement To Revenue 0.19  0.10 
Capex To Revenue 0.05  0.04 
Revenue Per Share 9.10  9.56 
Ebit Per Revenue 0.25  0.16 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY